Sign In
Buy SNY
$43.75
-0.230 (-0.523%)
At Close: Jul 21, 2026
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI
02:50pm, Sunday, 20'th Oct 2024
France will take a stake in Sanofi 's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro newspaper that U.S. priv
SNY Inks Deal With Orano Med for Next-Generation Radioligand Therapies
01:05pm, Thursday, 17'th Oct 2024
Sanofi inks an agreement with Orano Med to develop next-generation radioligand medicines to treat rare cancers.
PAI Partners makes higher offer for Sanofi's Opella, says Le Monde
07:40am, Thursday, 17'th Oct 2024
French private equity firm PAI Partners has submitted a new, higher offer for Sanofi's consumer health business Opella, the Le Monde newspaper said on Thursday, as PAI seeks to outbid U.S. rival Clayt
Press Release: Sanofi and Orano join forces to develop next-generation radioligand medicines
01:30am, Thursday, 17'th Oct 2024
Sanofi and Orano join forces to develop next-generation radioligand medicines Paris, October 17, 2024. Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targete
FLUBLOK® (Influenza Vaccine) US label updated with one of Sanofi's largest flu vaccine safety studies in pregnant individuals
12:26pm, Wednesday, 16'th Oct 2024
US FLUBLOK label1 updated to incorporate new safety study in pregnant individuals New safety data involving more than 48,000 pregnant individuals published in American Journal of Obstetrics and Gyneco
Workers at Sanofi to strike to protest consumer health unit sale, union official says
06:53am, Wednesday, 16'th Oct 2024
France's CGT and CFDT unions have called on workers at pharma company Sanofi to strike from Thursday to show their protest against a planned sale of a controlling stake in the firm's consumer health a
BRIDGEWATER, N.J. , Oct. 16, 2024 /PRNewswire/ -- Sanofi announced today it will contribute $18 million to three Historically Black Medical Schools to help the institutions work to increase diversity
France considering stake in Sanofi's Opella, minister says
11:47am, Tuesday, 15'th Oct 2024
France is considering taking a stake in Sanofi's Opella arm, said finance minister Antoine Armand, to allay concerns that the French drugmaker's plans to sell a 50% stake in Opella to a U.S. private e
Should Value Investors Buy Sanofi (SNY) Stock?
10:49am, Monday, 14'th Oct 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
French government seeking job guarantees from Sanofi over Doliprane production sites
07:01am, Monday, 14'th Oct 2024
The French government is seeking job guarantees from drugmaker Sanofi regarding its Doliprane production sites in the event of a sale of its consumer health branch, Economy Minister Antoine Armand sai
Sanofi in talks to sell consumer healthcare business that makes Dulcolax
04:32am, Friday, 11'th Oct 2024
Sanofi on Friday said it's in talks with the private equity firm CD&R to sell just over half of its consumer healthcare business, in a deal that could yield billions of dollars for the French drugmake
Sanofi in talks to sell 50% stake in consumer health business to CD&R
02:43am, Friday, 11'th Oct 2024
Sanofi has entered into discussions with U.S. private equity firm Clayton Dubilier & Rice to sell a controlling 50% stake in its consumer health business Opella, the French pharmaceutical giant said o
Press Release: Sanofi in discussions to sell a controlling stake in Opella
02:30am, Friday, 11'th Oct 2024
Sanofi in discussions to sell a controlling stake in Opella Paris, October 11, 2024 . Sanofi today announces that the company has entered into negotiations with CD&R for the potential sale of a 50% co
CD&R nears deal to buy Sanofi's consumer unit for $16 bln, Bloomberg News reports
05:09pm, Thursday, 10'th Oct 2024
Private equity firm Clayton Dubilier & Rice (CD&R) is nearing a deal to acquire Sanofi's consumer health unit for about 15 billion euros ($16.4 billion), Bloomberg News reported on Thursday.
Denali-Sanofi scraps mid-stage study for multiple sclerosis drug
04:19pm, Thursday, 10'th Oct 2024
Drug developer Denali Therapeutics said on Thursday its partner Sanofi has discontinued a mid-stage study testing their experimental drug to treat multiple sclerosis as it failed to meet the main and
